Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approach
Background: Postmenopausal osteoporosis (PMOP) is a systemic metabolic disease with an imbalance of bone resorption and bone formation coupling as the basic pathogenesis. ZuoGui Wan (ZGW) can effectively ameliorate bone loss associated with decreased estrogen levels, the metabolic mechanisms and act...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Phytomedicine Plus |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667031324001854 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823861127063273472 |
|---|---|
| author | Yanchen Feng KaiKai Shi Dingming Li Shunzhi Yang Xue Dang Jinyao Li Yan Chen Jianping Yao Yunke Zhang Lu Sun Feixiang Liu |
| author_facet | Yanchen Feng KaiKai Shi Dingming Li Shunzhi Yang Xue Dang Jinyao Li Yan Chen Jianping Yao Yunke Zhang Lu Sun Feixiang Liu |
| author_sort | Yanchen Feng |
| collection | DOAJ |
| description | Background: Postmenopausal osteoporosis (PMOP) is a systemic metabolic disease with an imbalance of bone resorption and bone formation coupling as the basic pathogenesis. ZuoGui Wan (ZGW) can effectively ameliorate bone loss associated with decreased estrogen levels, the metabolic mechanisms and active ingredients involved remain unclear. Method: We evaluated the efficacy of ZGW on bone loss in ovariectomized (OVX) rats. The blood-entry components of ZGW were identified using ultra-high performance liquid chromatography-high resolution mass spectrometry. The metabolic mechanisms of ZGW against PMOP were elucidated through metabolomics. Components highly correlated with differential metabolites were identified via correlation analysis. The metabolic mechanism of ZGW against PMOP was further confirmed by combining network pharmacology and metabolomics results and constructing an in vitro cell model for validation. Result: ZGW reversed OVX-induced bone loss by enhancing bone density and improving bone microstructural integrity. Initially, 14 prototype components were identified in the serum of OVX rats following ZGW intervention. Metabolomics analysis revealed 33 differential metabolites involved in pathways such as arginine biosynthesis, and the metabolism of arginine, proline, histidine, aspartate, and glutamate. Additionally, network pharmacology and molecular docking analyses further dissected the active ingredients of ZGW, constructing a ''Compound-Targets-Metabolic pathway-Metabolites'' network against PMOP. Conclusion: this study comprehensively revealed the metabolic mechanism and active ingredients of ZGW against PMOP for the first time, providing a new perspective on the study of the mechanism of ZGW against PMOP. |
| format | Article |
| id | doaj-art-a76f26235a3a4f0e838682aba4b5b87e |
| institution | Kabale University |
| issn | 2667-0313 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Phytomedicine Plus |
| spelling | doaj-art-a76f26235a3a4f0e838682aba4b5b87e2025-02-10T04:35:15ZengElsevierPhytomedicine Plus2667-03132025-02-0151100711Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approachYanchen Feng0KaiKai Shi1Dingming Li2Shunzhi Yang3Xue Dang4Jinyao Li5Yan Chen6Jianping Yao7Yunke Zhang8Lu Sun9Feixiang Liu10Department of Neuropsychiatry and Psychology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, PR China; The First Clinical Medical School, Henan university of Chinese medicine, Zhengzhou, PR ChinaSchool of Medicine, Henan university of Chinese medicine, Zhengzhou, PR ChinaSchool of Medicine, Henan university of Chinese medicine, Zhengzhou, PR ChinaSchool of Medicine, Henan university of Chinese medicine, Zhengzhou, PR ChinaTraditional Chinese Medicine (Zhong Jing) School, Henan University of Chinese Medicine, Zhengzhou, PR ChinaTraditional Chinese Medicine (Zhong Jing) School, Henan University of Chinese Medicine, Zhengzhou, PR ChinaDepartment of Endocrinology, Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou, PR ChinaTraditional Chinese Medicine (Zhong Jing) School, Henan University of Chinese Medicine, Zhengzhou, PR ChinaSchool of Rehabilitation Medicine, Henan University of Chinese Medicine, Zhengzhou, PR ChinaThe First Clinical Medical School, Henan university of Chinese medicine, Zhengzhou, PR ChinaDepartment of Neuropsychiatry and Psychology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, PR China; The First Clinical Medical School, Henan university of Chinese medicine, Zhengzhou, PR China; Corresponding author.Background: Postmenopausal osteoporosis (PMOP) is a systemic metabolic disease with an imbalance of bone resorption and bone formation coupling as the basic pathogenesis. ZuoGui Wan (ZGW) can effectively ameliorate bone loss associated with decreased estrogen levels, the metabolic mechanisms and active ingredients involved remain unclear. Method: We evaluated the efficacy of ZGW on bone loss in ovariectomized (OVX) rats. The blood-entry components of ZGW were identified using ultra-high performance liquid chromatography-high resolution mass spectrometry. The metabolic mechanisms of ZGW against PMOP were elucidated through metabolomics. Components highly correlated with differential metabolites were identified via correlation analysis. The metabolic mechanism of ZGW against PMOP was further confirmed by combining network pharmacology and metabolomics results and constructing an in vitro cell model for validation. Result: ZGW reversed OVX-induced bone loss by enhancing bone density and improving bone microstructural integrity. Initially, 14 prototype components were identified in the serum of OVX rats following ZGW intervention. Metabolomics analysis revealed 33 differential metabolites involved in pathways such as arginine biosynthesis, and the metabolism of arginine, proline, histidine, aspartate, and glutamate. Additionally, network pharmacology and molecular docking analyses further dissected the active ingredients of ZGW, constructing a ''Compound-Targets-Metabolic pathway-Metabolites'' network against PMOP. Conclusion: this study comprehensively revealed the metabolic mechanism and active ingredients of ZGW against PMOP for the first time, providing a new perspective on the study of the mechanism of ZGW against PMOP.http://www.sciencedirect.com/science/article/pii/S2667031324001854Zuogui wanPostmenopausal osteoporosisBlood entry componentMetabolomicsNetwork pharmacologyMolecular docking |
| spellingShingle | Yanchen Feng KaiKai Shi Dingming Li Shunzhi Yang Xue Dang Jinyao Li Yan Chen Jianping Yao Yunke Zhang Lu Sun Feixiang Liu Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approach Phytomedicine Plus Zuogui wan Postmenopausal osteoporosis Blood entry component Metabolomics Network pharmacology Molecular docking |
| title | Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approach |
| title_full | Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approach |
| title_fullStr | Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approach |
| title_full_unstemmed | Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approach |
| title_short | Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approach |
| title_sort | elucidating the metabolic mechanisms and active constituents of zuogui wan in combatting postmenopausal osteoporosis a metabolomics and network pharmacology approach |
| topic | Zuogui wan Postmenopausal osteoporosis Blood entry component Metabolomics Network pharmacology Molecular docking |
| url | http://www.sciencedirect.com/science/article/pii/S2667031324001854 |
| work_keys_str_mv | AT yanchenfeng elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach AT kaikaishi elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach AT dingmingli elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach AT shunzhiyang elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach AT xuedang elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach AT jinyaoli elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach AT yanchen elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach AT jianpingyao elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach AT yunkezhang elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach AT lusun elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach AT feixiangliu elucidatingthemetabolicmechanismsandactiveconstituentsofzuoguiwanincombattingpostmenopausalosteoporosisametabolomicsandnetworkpharmacologyapproach |